Science
CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancer – MedPage Today
Large proportion of intermediate- to high-risk patients could avoid aggressive therapy
A prognostic risk estimator that incorporates genomic data and clinical factors could allow for the elimination of androgen deprivation therapy (ADT) in some men with intermediate- or high-risk prostate cancer following radiation therapy (RT), a researcher reported.
In a retrospective validation study involving nearly 750 men who received dose-escalated RT, those with a combined clinical cell-cycle risk (CCR) score below a cutoff of 2.112 had a 10-year risk of distant metastasis of just 4.1%, regardless…
-
Noosa News16 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business19 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
Business18 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General14 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse